Cite

HARVARD Citation

    Paprcka, S. et al. (n.d.). 509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer. Journal for immunotherapy of cancer. pp. A313-A314. [Online]. 
  
Back to record